Who Should-and Can-Get Lecanemab, the New Alzheimer Disease Drug? Rubin R. JAMA 2023 Sep 27. doi: 10.1001/jama.2023.14443.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rubin R. Who Should-and Can-Get Lecanemab, the New Alzheimer Disease Drug? JAMA 2023 Sep 27. doi: 10.1001/jama.2023.14443.
PMID: 37755935